IP Library Granted Patent US 7,807,786
Granted Patent B2
US 7,807,786 · App. 12/069,064 · Granted Oct 5, 2010

BSL2v1c2 polypeptides

Assignee: Bristol-Myers Squibb Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,807,786
App. No.
12/069,064
Granted
Oct 5, 2010
Kind
B2
Abstract

The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

Claims (21)

1. An isolated polypeptide comprising a sequence selected from the group consisting of:

(a) an isolated polypeptide comprising amino acids 1 to 316 of SEQ ID NO:13;

(b) an isolated polypeptide comprising amino acids 2 to 316 of SEQ ID NO:13; and

(c) an isolated polypeptide comprising amino acids 29 to 316 of SEQ ID NO:13.

2. The isolated polypeptide of claim 1 , wherein said polypeptide is (a).

3. The isolated polypeptide of claim 1 , wherein said polypeptide is (b).

4. The isolated polypeptide of claim 1 , wherein said polypeptide is (c).

5. An isolated polypeptide comprising a polypeptide encoded by the cDNA clone contained in plasmid BSL2-L165-35b in ATCC Deposit No. PTA-1988.

6. An isolated polypeptide produced by a method comprising:

(a) culturing an isolated recombinant host cell comprising a vector that comprises the coding region encoding the polypeptide of claim 1 under conditions such that said polypeptide is expressed; and

(b) recovering said polypeptide.

7. The isolated polypeptide of claim 1 wherein said polypeptide further comprises a heterologous polypeptide.

8. The isolated polypeptide of claim 7 wherein said heterologous polypeptide is the Fc domain of human IgG.

9. An isolated polypeptide comprising a polypeptide encoded by the cDNA clone contained in plasmid BSL2v1c2Ig in ATCC Deposit No. PTA-4056.

10. An isolated polypeptide comprising a sequence selected from the group consisting of:

(a) an isolated polypeptide comprising amino acids 1 to 247 of SEQ ID NO:13;

(b) an isolated polypeptide comprising amino acids 2 to 247 of SEQ ID NO:13; and

(c) an isolated polypeptide comprising amino acids 29 to 247 of SEQ ID NO:13.

11. The isolated polypeptide of claim 10 , wherein said polypeptide is (a).

12. The isolated polypeptide of claim 10 , wherein said polypeptide is (b).

13. The isolated polypeptide of claim 10 , wherein said polypeptide is (c).

Continuity (6)
Division 1134646800 · Feb 2, 2006
Division 1007702300 · Feb 15, 2002
Continuation In Part 0987533800 · Jun 6, 2001
Provisional Application 6027210700 · Feb 28, 2001
Provisional Application 6020981100 · Jun 6, 2000
Related Publication 20100125127A1 · May 20, 2010